DIPIVEFRIN HYDROCHLORIDE Drug Patent Profile
When do Dipivefrin Hydrochloride patents expire, and when can generic versions of Dipivefrin Hydrochloride launch?
Dipivefrin Hydrochloride is a drug marketed by Bausch And Lomb and Falcon Pharms and is included in two NDAs.
The generic ingredient in DIPIVEFRIN HYDROCHLORIDE is dipivefrin hydrochloride. There is one drug master file entry for this compound. Additional details are available on the dipivefrin hydrochloride profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DIPIVEFRIN HYDROCHLORIDE?
- What are the global sales for DIPIVEFRIN HYDROCHLORIDE?
- What is Average Wholesale Price for DIPIVEFRIN HYDROCHLORIDE?
Summary for DIPIVEFRIN HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 58 |
| Clinical Trials: | 1 |
| Patent Applications: | 702 |
| DailyMed Link: | DIPIVEFRIN HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for DIPIVEFRIN HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Insignis Therapeutics, Inc. | PHASE1 |
| Washington University School of Medicine | PHASE1 |
US Patents and Regulatory Information for DIPIVEFRIN HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch And Lomb | DIPIVEFRIN HYDROCHLORIDE | dipivefrin hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 074188-001 | May 19, 1995 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Falcon Pharms | DIPIVEFRIN HYDROCHLORIDE | dipivefrin hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 073636-001 | Jun 30, 1994 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
